Effectiveness and Safety of Adalimumab Biosimilars in Pediatric Psoriasis: A Multi-Center International Experience [0.03%]
阿达木单抗生物类似药治疗儿童银屑病的有效性和安全性：多中心国际经验
Cristina Bertoli,Tiago Torres,Paolo Romita et al.
Cristina Bertoli et al.
Background: Many adalimumab biosimilars have been approved for the same indications as their originator (Humira ®). However, data on their efficacy and safety in children with psoriasis are scarce. ...
Patient-Reported Well-Being in Value-Based Routine Care Using Tildrakizumab: 52-week Interim Data of the Phase IV Positive Study [0.03%]
基于价值的常规护理中使用Tildrakizumab患者的报告福利：Positive研究的第52周中期数据
Ulrich Mrowietz,Rachel Sommer,Sascha Gerdes et al.
Ulrich Mrowietz et al.
Purpose: Psoriasis profoundly impairs patients' social, emotional, and physical condition, impacting on their overall well-being. Tildrakizumab is an interleukin-23p19 inhibitor labelled for the treatment of moderate-to-s...
Evolution of Drug Supply for Psoriasis from 2010 to 2022 - Real-World Claims Data Analysis in Germany [0.03%]
2010年至2022年德国银屑病药物供应的演变——真实世界理赔数据分析
Kristina Hagenström,Theresa Klinger,Brigitte Stephan et al.
Kristina Hagenström et al.
Purpose: The management of psoriasis has undergone substantial evolution; however, the long-term prescription trends remain ambiguous. This study utilised a comprehensive data set of psoriasis drug prescriptions in German...
Acupoint Injection Combined with BCG-PSN and Thymosin Enteric-Coated Tablets Improve China Han Psoriasis Vulgaris by Regulating T Cell Subsets [0.03%]
皮内注射BCG-PSN与胸腺肽肠溶片联合耳穴贴压治疗汉族寻常型银屑病患者疗效及对T淋巴细胞亚群影响的观察
Junqin Li,Xincheng Zhao,Hong Pan et al.
Junqin Li et al.
Purpose: Psoriasis is a common chronic inflammatory skin disease. Acupoint injection is reported to be used for the treatment of psoriasis, however its mechanism is not yet clear. The study aimed to investigate the effici...
Are Systemic Drug Choices for Psoriasis by Dermatologists Compatible with Psoriatic Arthritis? Data from the German National Psoriasis Registry PsoBest [0.03%]
德国全国银屑病登记数据库PsoBest中皮肤科医生治疗银屑病的系统用药选择与银屑病关节炎的关系如何？
Christina Sorbe,Secilay Kargin,Ralph von Kiedrowski et al.
Christina Sorbe et al.
Background: Plaque-type psoriasis (PSO) is a chronic inflammatory systemic skin disease. Psoriatic arthritis (PsA) is a frequent component requiring early treatment to prevent joint damage. Guidelines recommend differenti...
Pediatric Pustular Psoriasis in Southern China: A 12-Year Retrospective Analysis of 41 Cases Focusing on Clinical Characteristics and Treatment Outcomes [0.03%]
中国南部地区儿童脓疱型银屑病的临床特点及疗效回顾分析（12年，41例）
Jinling Tang,Zhaojuan Hou,Wei Liao et al.
Jinling Tang et al.
Background: Pustular psoriasis (PP) is a systemic inflammatory disease that rarely occurs in children but adversely affects their quality of life. Objecti...
Predictors of Quality of Life in Psoriasis Patients: Insights from a Cross-Sectional Study [0.03%]
中国 psoriasis 患者生活质量影响因素分析：一项横断面调查研究的新发现
Patrycja Walniczek,Malgorzata Ponikowska,Ewelina Barbara Kolarczyk et al.
Patrycja Walniczek et al.
Background: Psoriasis significantly impacts patients' mental health and social relationships, often leading to feelings of stigmatization and shame due to the visibility of skin lesions. This study aimed to identify facto...
Ling Ma,Xiaoli Chen,Mohammed Ali Ali Aziz et al.
Ling Ma et al.
Psoriasis and atopic dermatitis (AD), once viewed as mutually exclusive diseases, are increasingly recognized to co-occur in complex inflammatory phenotypes. We present a 17-year-old male with multimorbid atopic conditions, including persis...
Real-World Experience of Bimekizumab in a Cohort of 109 Patients Over 48 Weeks and Identification of Predictive Factors for an Early Super Response and Risk of Adverse Events [0.03%]
贝米珠单抗的现实世界经验：对109例患者长达48周的观察以及早期超强反应和不良事件风险预测因素的识别
Zeno Fratton,Stefano Bighetti,Luca Bettolini et al.
Zeno Fratton et al.
Introduction: Psoriasis is a chronic inflammatory skin disease significantly impairing quality of life. The introduction of biologic therapies, such as bimekizumab-a monoclonal antibody targeting IL-17A and IL-17F-has rev...
Infection Risk and Vaccination in the Management of Psoriasis: Considerations for Biologic Therapy [0.03%]
感染风险和疫苗接种在生物制剂治疗银屑病中的考虑因素
Laura Mateu-Arrom,Lluis Puig
Laura Mateu-Arrom
This narrative review examines critical considerations for biologic treatment in psoriasis patients, with a focus on infection risks, providing current recommendations and practical considerations for prevention, including vaccination, scre...